RxDoctor Payments Data

Leslie Petersen

Acute Care · Camarillo, CANPI 1992125082

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $339,114 of the $369,541 with a category attached, or 91.8%. AbbVie accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $139,241 and has fallen 66.1% since, to $47,155 in 2025. Among acute care clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$369,541in general payments, 2019–2025

Across 468 payments — averaging $789.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$370K
  • Galderma Laboratories, L.p.$22

What the payments were for

  • Consulting fees$5000%
  • Speaking & faculty fees$339,11492%
  • Travel & lodging$23,7116%
  • Food & beverage$6,1862%
  • Education$290%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)467$369,519
Galderma Laboratories, L.p.1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$369,541 in reported general payments places this provider in the 95th percentile of 1,153 acute care providers in California.

See all acute care providers in California

Other acute care in Camarillo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →